Support PenkeAmneal Pharmaceuticals, Inc. Class A Common Stock - Trending symbols
Latest News of Amneal Pharmaceuticals, Inc. Class A Common Stock
| Date | Title | Read |
|---|---|---|
| 2025-09-11 20:16 | Why Amneal (AMRX) Stock Is Up Today | Read |
Notifications
| Type | Notification | Date |
|---|---|---|
| RSI Overbought | Overbought RSI (Relative Strength Index) | 2025-09-09 |
Trends
| 2024-06-30 | 2024-09-30 | 2024-12-31 | 2025-03-31 | 2025-06-30 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Other Stockholders Equity | 545,701 | 7,532 | 553,233 | 6,973 | 560,206 | -14,400 | 545,806 | -658,339 | -112,533 | |
| Total Stockholder Equity | -63,724 | 6,259 | -57,465 | -35,967 | -93,432 | -15,835 | -109,267 | 1,125,702 | 1,016,435 | |
| Interest Expense | 65,703 | 16 | 65,719 | -208 | 65,511 | -3,849 | 61,662 | -118,601 | -56,939 | |
| EBITDA | 98,669 | 34,273 | 132,942 | 2,612 | 135,554 | -84,755 | 50,799 | -61,545 | -10,746 | |
| Operating Income | 34,449 | 45,635 | 80,084 | -4,436 | 75,648 | -61,455 | 14,193 | -24,939 | -10,746 | |
| EBIT | 74,198 | -39,749 | 34,449 | 41,382 | 75,831 | 2,517 | 78,348 | -84,482 | -6,134 | |
| Accumulated Other Comprehensive Income | 9,939 | -6,175 | 3,764 | 4,319 | 8,083 | -4,210 | 3,873 | -36,222 | -32,349 | |
| Total Other Income Expense Net | -231,293 | 189,120 | -42,173 | -39,680 | -81,853 | 37,978 | -43,875 | 48,573 | 4,698 | |
| Net Income | -240,081 | 237,691 | -2,390 | -3,468 | -5,858 | -4,236 | -10,094 | 22,011 | 11,917 | |
| Net Income from Continuing Operations | -240,081 | 237,691 | -2,390 | -3,468 | -5,858 | -4,236 | -10,094 | 39,777 | 29,683 | |
| Net Income Applicable to Common Shares | -120,808 | 118,119 | -2,689 | -1,644 | -4,333 | -2,610 | -6,943 | 18,860 | 11,917 | |
| Income before Tax | -2,043 | -14,276 | -16,319 | 6,398 | -9,921 | -222,810 | -232,731 | 234,911 | 2,180 | |
| Minority Interest | 44,165 | -11,505 | 32,660 | -26,027 | 6,633 | 9,649 | 16,282 | -123,618 | -107,336 | |
| Non Recurring | 3,945 | -1,870 | 2,075 | 18,977 | 21,052 | -12,841 | 8,211 | -9,042 | -831 | |
| Income Tax Expense | 359 | 2,289 | 2,648 | 1,401 | 4,049 | 91 | 4,140 | -7,601 | -3,461 | |
| Tax Provision | 359 | 2,289 | 2,648 | 1,401 | 4,049 | 91 | 4,140 | -7,601 | -3,461 | |
| Other Current Assets | 45,298 | 33,556 | 78,854 | -35,336 | 43,518 | 8,132 | 51,650 | -299,440 | -247,790 | |
| Research Development | 58,881 | -7,117 | 51,764 | 3,175 | 54,939 | -4,385 | 50,554 | -207,101 | -156,547 | |
| Gross Profit | 167,072 | 24,490 | 191,562 | 20,936 | 212,498 | -13,987 | 198,511 | -593,125 | -394,614 | |
| Total Operating Expenses | 143,568 | -1,078 | 142,490 | -1,394 | 141,096 | 855 | 141,951 | -201,274 | -59,323 |
Comments
How you think about this?